Allergy Diagnostics And Treatment Market By Product Type (Assay Kits, Consumables, Services), By Test Type (In Vivo Tests, In Vitro Tests), By Treatment Type (Antihistamines, Autoinjectable Epinephrine, Corticosteroids, Decongestants, Immuno Modulators, Immunotherapy, Leukotriene Inhibitors, Mast Cell Stabilizers, Nasal Anticholinergics), By Allergen Type (Food Allergen, Inhaled Allergen, Drug Allergen, Other Allergen) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025
Allergy is the immune reaction to foreign body called allergen; it may arise due to food consumed or inhaled into lungs or in contact with skin through injectable agent or touch. Allergic diseases rank fifth among the leading chronic diseases across all age groups in U.S. Over the period of 50 years of global industrialization, there is a substantial rise in prevalence of allergic diseases. According to the World Allergy Organization (WAO) study, the prevalence of allergy ranges from 10% - 40% across all age groups of population. Allergic disease affects more than one billion people worldwide and is anticipated to reach 4 billion in 2050. This increases both direct and indirect burden in terms of rise in healthcare cost, loss of productivity and adverse effect on quality of life. Thus increase in prevalence of allergic diseases and novel diagnostic and treatment products entering the market are the key factors governing the growth of allergy diagnostics and treatment market.
The report titled “Allergy Diagnostics and Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall allergy diagnostics and treatment market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of diagnostic products, allergens, tests, treatments and different geographies. The diagnostic product types studied for analyzing the overall global allergy diagnostics and treatment market are majorly segmented into instruments, consumables, services and other products. By allergen type, the allergy diagnostics and treatment market is segmented into food, inhaled, drug and other allergens. On the basis of test types, it is further segmented as in vivo and in vitro tests. According to treatment type, the market is segmented into antihistamines, autoinjectables epinephrine, corticosteroids, decongestants, immunomodulators, immunotherapy, leukotriene inhibitors, mast cell stabilizers and nasal anticholinergics.
Geographically, the global allergy diagnostics and treatment market is studied for the following regional markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of LATAM
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year. Further cross-sectional presented in terms of diagnostic products, allergens, test, treatment and constituent country level markets is also included in this section.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global allergy diagnostics and treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global allergy diagnostics and treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global allergy diagnostics and treatment market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.
Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the allergy diagnostics and treatment market. The key players profiled in this report are Alcon Laboratories, Inc., bioMerieux, Danaher Corporation, Hitachi Chemical Diagnostics, HOB Biotech Group, Hycor Biomedical, Lincoln Diagnostics, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Thermo Fisher Scientific and others.
Based on the type of products, the global allergy diagnostics market is segmented as follows:
- Assay Kits
- Consumables
- Instruments
Among the product types, consumables segment dominate the global allergy diagnostics and treatment market and it is also the fastest growing market followed by assay kits and instruments. Consumables are required on a large scale, thus high volume and low cost plays important role in occupying greater share in global allergy diagnostics and treatment market. The currently available assay are easy to use and handle, showing high precision results. These diagnostic kits are more time saving and show enhanced sensitivity.
Based on the type of tests, the global allergy diagnostics market is segmented as follows:
- In vivo tests
- In vitro tests
In 2016, in vivo tests dominate the global allergy diagnostics market. In vivo test is rapid, sensitive and cost efficient, and therefore is more preferred over in vitro testing. Currently, skin test are the best available option for detection of allergen specific IgE. Adoption of skin tests in healthcare professionals and patients is high. In vitro tests are carried out in certain circumstances such as, if the skin is abnormal or the history of sensitivity is observed in patient. While rising demand of less invasive diagnostics, technological advancement in laboratories would boast the growth of in vitro test segment.
Based on the type of treatment, the global allergy treatment market is segmented as follows:
- Antihistamines
- Autoinjectable Epinephrine
- Corticosteroids
- Decongestants
- Immunomodulators
- Immunotherapy
- Leukotriene Inhibitors
- Mast Cell Stabilizers
- Nasal Anticholinergics
In 2016, antihistamine is the most commonly used treatment for allergic diseases, thus dominates the global allergy treatment market. Next followed up market is of corticosteroids, which are highly effective drugs for allergies. Immunotherapy is expected to be the fastest growing segment in allergy treatment market. Immunotherapy is showing fast adoption as it is cost effective, decreases sensitivity to allergens and provides long lasting relief from allergy symptoms.
Based on the type of allergen, the global allergy diagnostics and treatment market is segmented as follows:
- Food Allergens
- Inhaled Allergens
- Drug Allergens
- Other
Rising incidence of inhaled allergies and asthma due to growing pollution, urbanization contribute to the growth of allergy diagnostics and treatment market. Thus inhaled allergens occupy the largest revenue share for the year 2016. Allergic rhinitis affects almost 10% - 30% of the adult population and 40% of children. Global warming, alteration in pollination season are some of the major reasons for growing incidence of asthma and allergic rhinitis. Food allergies are commonly observed in children than in adults. Drug allergen is anticipated to be the fastest growing segment during the forecast period 2017-2025.
For the purpose of this study, the global allergy diagnostic and treatment market is geographically categorized into:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
At present, North America occupies the largest share of global allergy diagnostic and treatment market followed by Europe. Rising incidence of allergic diseases particularly related to respiratory function, increasing awareness of allergy diagnostics, well supported healthcare structure, favorable reimbursement policies and enhanced diagnostic technology are some of the major driving factors for allergy diagnostics and treatment market. Around 150 million Europeans suffer from chronic allergic diseases and it is predicted to cover almost half the population of Europe by 2025. Rise in geriatric population are key factors which would further fuel the allergy diagnostics and treatment market. Asia Pacific is anticipated to be the fastest growing allergy diagnostics and treatment market in the forecast period. Rising prevalence of allergic diseases and asthma, particularly in developing countries poses major threat to health and economies. Thus high unmet needs, improving healthcare infrastructure, rising pollution, and increasing disposable income are some of the factors governing the demand of allergy diagnostics and treatment market in Asia Pacific region.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Allergy Diagnostics and Treatment Market Portraiture
2.1.1. Global Allergy Diagnostics and Treatment Market, by Product Type, 2016
2.1.2. Global Allergy Diagnostics and Treatment Market, by Allergen Type, 2016
2.1.3. Global Allergy Diagnostics and Treatment Market, by Test Type, 2016
2.1.4. Global Allergy Diagnostics and Treatment Market, by Treatment Type, 2016
2.1.5. Global Allergy Diagnostics and Treatment Market, by Geography, 2016
Chapter 3. Allergy Diagnostics and Treatment Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Allergy Diagnostics Market, by Product Type
4.3. Assay Kits
4.4. Consumables
4.5. Services
Chapter 5. Global Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global Allergy Diagnostics Market, by Test Type
5.3. In vivo tests
5.4. In vitro tests
Chapter 6. Global Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. Attractive Investment Proposition: Global Allergy Treatment Market, by Treatment Type
6.3. Antihistamines
6.4. Autoinjectable Epinephrine
6.5. Corticosteroids
6.6. Decongestants
6.7. Immunomodulators
6.8. Immunotherapy
6.9. Leukotriene Inhibitors
6.10. Mast Cell Stabilizers
6.11. Nasal Anticholinergics
Chapter 7. Global Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. Attractive Investment Proposition: Global Allergy Diagnostics and Treatment Market, by Allergen Type
7.3. Food Allergen
7.4. Inhaled Allergen
7.5. Drug Allergen
7.6. Other Allergen
Chapter 8. Global Allergy Diagnostics and Treatment Market, by Geography, 2015 – 2025 (US$ Mn)
8.1. Overview
8.2. North America Allergy Diagnostics and Treatment Market Analysis, 2015 – 2025
8.2.1. North America Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
8.2.2. North America Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
8.2.3. North America Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
8.2.4. North America Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
8.2.5. North America Allergy Diagnostics and Treatment Market, by Country, 2015 – 2025 (US$ Mn)
8.2.5.1. U.S.
8.2.5.2. Canada
8.3. Europe Allergy Diagnostics and Treatment Market Analysis, 2015 – 2025
8.3.1. Europe Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
8.3.2. Europe Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
8.3.3. Europe Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
8.3.4. Europe Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
8.3.5. Europe Allergy Diagnostics and Treatment Market, by Country, 2015 – 2025 (US$ Mn)
8.3.5.1. U.K.
8.3.5.2. Germany
8.3.5.3. France
8.3.5.4. Rest of Europe
8.4. Asia Pacific Allergy Diagnostics and Treatment Market Analysis, 2015 – 2025
8.4.1. Asia Pacific Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
8.4.2. Asia Pacific Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
8.4.3. Asia Pacific Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
8.4.4. Asia Pacific Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
8.4.5. Asia Pacific Allergy Diagnostics and Treatment Market, by Country, 2015 – 2025 (US$ Mn)
8.4.5.1. Japan
8.4.5.2. China
8.4.5.3. India
8.4.5.4. Rest of APAC
8.5. Latin America Allergy Diagnostics and Treatment Market Analysis, 2015 – 2025
8.5.1. Latin America Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
8.5.2. Latin America Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
8.5.3. Latin America Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
8.5.4. Latin America Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
8.5.5. Latin America Allergy Diagnostics and Treatment Market, by Country, 2015 – 2025 (US$ Mn)
8.5.5.1. Brazil
8.5.5.2. Mexico
8.5.5.3. Rest of Latin America
8.6. Middle East & Africa (MEA) Allergy Diagnostics and Treatment Market Analysis, 2015 – 2025
8.6.1. MEA Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
8.6.2. MEA Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
8.6.3. MEA Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
8.6.4. MEA Allergy Diagnostics and Treatment Market, by Allergen, 2015 – 2025 (US$ Mn)
8.6.5. MEA Allergy Diagnostics and Treatment Market, by Region, 2015 – 2025 (US$ Mn)
8.6.5.1. UAE
8.6.5.2. Saudi Arabia
8.6.5.3. South Africa
8.6.5.4. Rest of MEA
Chapter 9. Company Profiles
9.1. Alcon Laboratories, Inc.
9.1.1. Business Description
9.1.2. Financial Information (Subject to data availability)
9.1.3. Product Portfolio
9.1.4. Key Developments
9.2. BioMerieux, Inc
9.3. Danaher Corporation
9.4. Hitachi Chemical Diagnostics, Inc
9.5. HOB Biotech Group Co.,Ltd.
9.6. Hycor Biomedical, Inc.
9.7. Lincoln Diagnostics, Inc.
9.8. Omega Diagnostics Plc.
9.9. Siemens Healthcare Diagnostic, Inc.
9.10. Stallergenes Greer, Inc.
9.11. Thermo Fisher Scientific, Inc.
9.12. Other Notable Players
TABLE 1 Global Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Allergy Treatment Market, by Treatment Type, 2015 – 2025
(US$ Mn)
TABLE 4 Global Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 8 North America Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
TABLE 9 North America Allergy Diagnostics and Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 13 Europe Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
TABLE 14 Europe Allergy Diagnostics and Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Allergy Diagnostics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 16 Asia Pacific Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Allergy Treatment Market, by Treatment Type, 2015 – 2025(US$ Mn)
TABLE 18 Asia Pacific Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025(US$ Mn)
TABLE 19 Asia Pacific Allergy Diagnostics and Treatment Market, by Country, 2015 – 2025(US$ Mn)
TABLE 20 Latin America Allergy Diagnostics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 21 Latin America Allergy Diagnostics Market, by Test Type, 2015 – 2025(US$ Mn)
TABLE 22 Latin America Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 23 Latin America Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025(US$ Mn)
TABLE 24 Latin America Allergy Diagnostics and Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East and Africa Allergy Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 26 Middle East and Africa Allergy Diagnostics Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 27 Middle East and Africa Allergy Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 28 Middle East and Africa Allergy Diagnostics and Treatment Market, by Allergen Type, 2015 – 2025 (US$ Mn)
TABLE 29 Middle East and Africa Allergy Diagnostics and Treatment Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 30 Alcon Laboratories, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 31 BioMerieux, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 32 Danaher Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 33 Hitachi Chemical Diagnostics,Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 34 HOB Biotech Group Co.,Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 35 Hycor Biomedical, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 36 Lincoln Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 37 Omega Diagnostics Plc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 38 Siemens Healthcare Diagnostic, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 39 Stallergenes Greer, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 40 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
FIG. 1 Allergy Diagnostics and Treatment: Market Segmentation
FIG. 2 Global Allergy Diagnostics Market Share, by Product Type, 2016 (US$ Mn)
FIG. 3 Global Allergy Diagnostics and Treatment Market Share, by Allergen Type, 2016 (US$ Mn)
FIG. 4 Global Allergy Diagnostics Market Share, by Test Type, 2016 (US$ Mn)
FIG. 5 Global Allergy Treatment Market, by Treatment Type, 2016 (US$ Mn)
FIG. 6 Global Allergy Diagnostics and Treatment Market, by Geography, 2016 (Value %)
FIG. 7 Attractive Investment Proposition, by Geography
FIG. 8 Market Competition Landscape, by Key Players, 2016
FIG. 9 Global Allergy Diagnostics Instruments Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Allergy Diagnostics Consumables Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Allergy Diagnostics Assay Kits Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Allergy Diagnostics and Treatment Food Allergen Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Allergy Diagnostics and Treatment Inhaled Allergen Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Allergy Diagnostics and Treatment Drug Allergen Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Allergy Diagnostics and Treatment Others Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Allergy Diagnostics In-vivo Test Market, 2015 – 2025 (US$ Mn)
FIG. 17 Global Allergy Diagnostics In vitro Test Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Allergy Treatment Antihistamines Market, 2015 – 2025 (US$ Mn)
FIG. 19 Global Allergy Treatment Autoinjectable Epinephrine Market, 2015 – 2025 (US$ Mn)
FIG. 20 Global Allergy Treatment Corticosteroids Market, 2015 – 2025 (US$ Mn)
FIG. 21 Global Allergy Treatment Decongestants Market, 2015 – 2025 (US$ Mn)
FIG. 22 Global Allergy Treatment Immunomodulators Market, 2015 – 2025 (US$ Mn)
FIG. 23 Global Allergy Treatment Immunotherapy Market, 2015 – 2025 (US$ Mn)
FIG. 24 Global Allergy Treatment Leukotriene Inhibitors Market, 2015 – 2025 (US$ Mn)
FIG. 25 Global Allergy Treatment Mast Cell Stabilizers Market, 2015 – 2025 (US$ Mn)
FIG. 26 Global Allergy Treatment Nasal Anticholinergics Market, 2015 – 2025 (US$ Mn)
FIG. 27 U.S. Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 28 Canada Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 29 U.K. Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 30 Germany Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 31 France Allergy Diagnostics and Treatment Market, 2015-2025 (US$ Mn)
FIG. 32 Rest of Europe Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 33 Japan Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 34 China Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 35 India Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 36 Rest of Asia Pacific Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 37 Brazil Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 38 Mexico Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 39 Rest of Latin America Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 40 UAE Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 41 Saudi Arabia Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 42 South Africa Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 43 Rest of Middle East and Africa Allergy Diagnostics and Treatment Market, 2015 – 2025 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)